LifeMD Soars 11.47% on Telehealth Revenue Boost

On May 7, 2025, LifeMD's stock surged by 11.47% in pre-market trading, reflecting a significant boost in investor confidence and market sentiment.

LifeMD has recently raised its 2025 revenue guidance to $275 million, primarily driven by the growth in its telehealth services. This strategic move underscores the company's commitment to expanding its digital healthcare offerings and capitalizing on the increasing demand for remote medical consultations.

The company's proactive approach to enhancing its telehealth capabilities has been well-received by investors, who see this as a key growth driver for the future. The positive market response indicates that LifeMD's initiatives are resonating with stakeholders, positioning the company for sustained growth in the coming years.